Effects of acute and chronic administration of high-dose corticosterone and dexamethasone on regional brain dopamine and serotonin metabolism in rats.
1. The effects of acute and chronic treatment with high-dose corticosterone (50 mg/kg) and dexamethasone (0.7 mg/kg) on monoamines and their metabolites levels in four regions of the rat brain were investigated. 2. Acute corticosterone and dexamethasone treatment decreased serotonin (5-HT) levels, but did not alter dopamine (DA),3,4-dihydroxyphenylacetic acid (DOPAC), homovanillic acid (HVA) or 5-hydroxyindoleacetic acid (5-HIAA) levels in any of the brain regions. 3. Chronic corticosterone treatment significantly increased the HVA and 5-HIAA levels only in the medial prefrontal cortex, while chronic dexamethasone treatment did not alter. Chronic corticosterone and dexamethasone treatment did not change DA, DOPAC or 5-HT levels in any of the brain regions. 4. These findings suggest that chronic treatment with high-dose corticosterone activates the dopaminergic and serotonergic neurotransmission in the medial prefrontal cortex.